| 1. |
Gordon MY. (1993) Human haemopoietic stem cell assays. Blood Rev. 7(3): 190–197.
|
| |
| 2. |
Pessina A, Albella B, Bayo M, Bueren J, Brantom P, Casati S, Croera C, Gagliardi G, Foti P, Parchment R, Parent-Massin D,
Schoeters G, Sibiril Y, Van Den Heuvel R, Gribaldo L. (2003) Application of the CFU-GM assay to predict acute drug-induced
neutropenia: an International Blind Trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive
xenobiotics. Toxicol. Sci. 75: 355–367.
|
| |
| 3. |
McNiece I, Andrews R, Stewart M, Clarke S, Boone T, Quesenberry P. (1989) Action of interleukin-3, G-CSF, and GM-CSF on highly
enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF. Blood
74(1): 110–114.
|
| |
| 4. |
Bacigalupo A, Piaggio G, Podesta M, Figari O, Benvenuto F, Sogno G, Tedone E, Raffo MR, Grassia L, Ferrero R, et al. (1995)
Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation. Bone Marrow Transplant. 15(2): 221–226.
|
| |
| 5. |
Torres A, Alonso MC, Gomez-Villagran JL, Manzanares MR, Martinez F, Gomez P, Garcia JM, Andres P, Gomez C, Torre MA, et al.
(1985) No influence of number of donor CFU-GM on granulocyte recovery in bone marrow transplantation for acute leukemia. Blut
50(2): 89–94.
|
| |
| 6. |
Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA, Dick
JE. (1996) Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications
for gene therapy. Nat. Med. 2(12): 1329–1337.
|
| |
| 7. |
Eaves C, Miller C, Cashman J, Conneally E, Petzer A, Zandstra P, Eaves A. (1997) Hematopoietic stem cells: inferences from
in vivo assays. Stem Cells
15 (Suppl 1): 1–5.
|
| |
| 8. |
Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. (1998) A newly discovered class of human hematopoietic cells with SCID-repopulating
activity. Nat. Med. 4(9): 1038–45.
|
| |
| 9. |
Moore MA, Warren DJ. (1987) Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell
recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc. Natl. Acad. Sci. U.S.A. 84(20): 7134–7138.
|
| |
| 10. |
Clarke E, Rice GC, Weeks RS, Jenkins N, Nelson R, Bianco JA, Singer JW. (1996) Lisofylline inhibits transforming growth factor
beta release and enhances trilineage hematopoietic recovery after 5-fluorouracil treatment in mice. Cancer Res. 56(1): 105–112.
|
| |
| 11. |
Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F, Krystal G, Humphries RK. (1998) Targeted
disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12(11): 1610–1620.
|
| |
| 12. |
Stephenson JR, Axelrad AA, McLeod DL, Shreeve MM. (1971) Induction of colonies of hemaglobin-synthesising cells by erythropoietin
in vitro. Proc. Natl. Acad. Sci. U.S.A. 68: 1542–1556.
|
| |
| 13. |
Broxmeyer HE, Williams DE, Cooper S, Shadduch RK, Gillis S, Waheed A, Urdal DL, Bicknell DC. (1987) Comparative effects in
vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage
colony-stimulating factor on myelopoiesis in mice. J Clin. Invest. 79(3): 721–30.
|
| |
| 14. |
Williams DE, Namen AE, Mochizuki DY, Overell RW. (1990) Clonal growth of murine pre-B colony-forming cells and their targeted
infection by a retroviral vector: dependence on interleukin-7. Blood
75(5): 1132–1138.
|
| |
| 15. |
Banu N, Wang JF, Deng B, Groopman JE, Avraham H. (1995) Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand.
Blood
86(4): 1331–1338.
|
| |
| 16. |
Sandmaier BM, Storb R, Santos EB, Krizanac-Bengez, Lian T, McSweeney PA, Yu C, Schuening FG, Deeg HJ, Graham T. (1996) Allogeneic
transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors. Blood
87(8): 3508–3513.
|
| |
| 17. |
Moneta D, Geroni C, Valota O, Grossi P, de Jonge MJ, Brughera M, Colajori E, Ghielmini M, Sessa C. (2003) Predicting the maximum-tolerated
dose of PNU-159548 (4-demethoxy-3′-deamino-3′-aziridinyl-4′-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation. Eur. J. Cancer. 39(5): 675–683.
|
| |
| 18. |
Masubuchi N. (2006) Risk assessment of human myelotoxicity of anticancer drugs: a predictive model and the in vitro colony
forming unit granulocyte/macrophage (CFU-GM) assay. Pharmazie. Feb; 61(2): 135–9.
|
| |
| 19. |
MacVittie TJ, Farese AM, Davis TA, Lind LB, McKearn JP. (1999) Myelopoietin, a chimeric agonist of human Interleukin 3 and
granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman
primates. Exp. Hematol. 27: 1557–1568.
|
| |
| 20. |
Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Kato I, Donahue RE, Dunbar CE. (1998) Ex vivo expansion of genetically
marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood
92: 1131–1141.
|
| |
| 21. |
Farese AM, Herodin F, McKearn JP, Baurn C, Burton E, MacVittie TJ. (1996) Acceleration of hematopoietic reconstitution with
a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia. Blood
87: 581–591.
|
| |
| 22. |
Jonker M. (1990) The importance of non-human primates for preclinical testing of immunosuppressive monoclonal antibodies.
Semin. Immunol. 2(6): 427–436.
|
| |
| 23. |
Pessina A, Malerba I, Gribaldo L. (2005) Hematotoxicity testing by cell clonogenic assay in drug development and preclinical
trials. Curr. Pharm. Des. 11(8): 1055–1065.
|
| |
| 24. |
Ficoll-Paque® PLUS Instructions 71-7167-00AF, cell preparation, GE Healthcare, January 2006.
|
| |
| 25. |
Nissen-Druey C, Tichelli A, Meyer-Monard S. (2005) Human hematopoietic colonies in health and disease. Reprint of Acta Haematoplogica (ISSN 0001-5792) 113(1) (STI cat. no. 28760).
|
| |
| 26. |
Testa NG, Molineaux G. (ed.) (1993) Haematopoiesis: A Practical Approach. Oxford University Press, New York.
|
| |